2022. Use of ivermectin and nitazoxanide for treatment and prophylaxis of COVID-19: A systematic review. Research, Society and Development. 11, 8 (Jun. 2022), e43511831090. DOI:https://doi.org/10.33448/rsd-v11i8.31090.